Shares of semiconductor equipment provider ACM Research demonstrated resilience last Friday, closing 1.39% higher at $35.10. This upward move occurred despite recent filings revealing that several company executives sold approximately $6 million worth of stock during the first week of December.
Executive Sales Details
The most substantial transactions were executed by insider Fuping Chen. Over December 2nd and 3rd, Chen disposed of a total of 120,000 shares at average prices of $33.20 and $33.06, generating proceeds of roughly $3.98 million.
Close behind was Director David Wang, who sold 60,000 shares on December 4th at a weighted average price of $34.12, realizing about $2.05 million. Following this sale, Wang’s remaining holding stands at 802,708 shares, representing a reduction in his position of approximately 6.95%.
Context: Quarterly Results and Market Positioning
These insider sales follow the company’s third-quarter earnings report released one month prior. ACM Research posted robust revenue growth of 32% to $269.16 million for the period, surpassing analyst forecasts. However, its earnings per share of $0.36 fell short of the consensus estimate of $0.47.
Should investors sell immediately? Or is it worth buying ACM Research?
The market’s measured reaction to the share sales suggests investors are balancing the firm’s solid top-line expansion against the executives’ decision to realize gains. The equity currently trades in the upper segment of its 52-week range, which spans from $13.87 to $45.12.
From a technical perspective, the stock recently found support above the $33 level—the price zone where the bulk of Chen’s selling volume was absorbed. Sustained stability above the $34-$35 area could be interpreted as a positive signal.
Ongoing Investor Engagement and Outlook
ACM Research continues its dialogue with the investment community. The company is scheduled to co-host the 14th Annual NYC Summit in New York on December 16th. This event will provide management a platform to detail its outlook for 2026 and address inquiries concerning margin development.
Covering analysts currently rate the shares between “Hold” and “Buy,” focusing on ACM Research’s capacity to benefit from a recovering demand environment for semiconductor manufacturing equipment.
Ad
ACM Research Stock: Buy or Sell?! New ACM Research Analysis from December 6 delivers the answer:
The latest ACM Research figures speak for themselves: Urgent action needed for ACM Research investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from December 6.
ACM Research: Buy or sell? Read more here...
